Type | Public | |
Founded | 2008 | |
HQ | Mainz, DE | Map |
Website | biontech.de | |
Employee Ratings |
EUR | |
---|---|
Revenue (FY, 2020) | 482.3m |
Gross profit (FY, 2020) | 677.0m |
Net income (FY, 2020) | 15.2m |
EBITDA (FY, 2020) | (43.7m) |
EBIT (FY, 2020) | (82.4m) |
Market capitalization (25-May-2022) | 37.3b |
Closing stock price (25-May-2022) | 142.6 |
Cash (31-Dec-2020) | 1.2b |
EV | 36.3b |
EUR | FY, 2019 | FY, 2020 |
---|---|---|
Revenue | 108.6m | 482.3m |
Cost of goods sold | (15.9m) | (55.9m) |
Gross profit | 95.5m | 677.0m |
R&D expense | (198.9m) | (614.8m) |
EUR | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|
Revenue | 27.7m | 41.8m | 67.5m |
Cost of goods sold | (5.8m) | (5.7m) | (6.8m) |
Gross profit | 22.2m | 36.9m | 69.4m |
R&D expense | (65.1m) | (95.2m) | (227.7m) |
EUR | FY, 2019 | FY, 2020 |
---|---|---|
Cash | 519.1m | 1.2b |
Accounts Receivable | 11.9m | 165.5m |
Prepaid Expenses | 756.0k | 898.0k |
Inventories | 12.1m | 64.1m |
EUR | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|
Cash | 451.6m | 573.0m | 990.5m |
Accounts Receivable | 10.3m | 7.7m | 7.2m |
Prepaid Expenses | 980.0k | 1.0m | 724.0k |
Inventories | 9.6m | 8.6m | 12.4m |
EUR | FY, 2019 | FY, 2020 |
---|---|---|
Net Income | (179.2m) | 15.2m |
Depreciation and Amortization | 33.9m | 38.7m |
Inventories | (5.8m) | (49.8m) |
EUR | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|
Net Income | (53.4m) | (143.9m) | (351.7m) |
Depreciation and Amortization | 8.6m | 17.4m | 26.2m |
Inventories | 2.2m | 3.2m | (508.0k) |
EUR | FY, 2019 |
---|---|
EV/EBITDA | -48.9 x |
EV/EBIT | -39.8 x |
EV/CFO | -36.4 x |
Revenue/Employee | 90.5k |
Company Name | Date | Deal Size |
---|---|---|
Apta IT | ||
BioNTech Austria Beteiligungen GmbH | ||
BioNTech Business Services | ||
BioNTech Cell & Gene Therapies | ||
BioNTech Diagnostics | ||
BioNTech Innovative Manufacturing Services | ||
BioNTech Protein Therapeutics | ||
BioNTech Real Estate GmbH & Co. KG | ||
BioNTech Real Estate Verwaltungs | ||
BioNTech Research and Development |
BioNTech revenue breakdown by business segment: 30.8% from CLINICAL, 44.9% from MANUFACTURING, 21.6% from PRODUCT SALES & EXTERNAL SERVICES and 2.6% from Other
BioNTech has 77.81k Twitter Followers. The number of followers has increased 0.4% month over month and increased 1.9% quarter over quarter
194
Tweets
172
Following
77.8k
Followers
3
Tweets last 30 days
127.7
Avg. likes per Tweet
100%
Tweets with engagement
When was BioNTech founded?
BioNTech was founded in 2008.
Who are BioNTech key executives?
BioNTech's key executives are Sean Marett, Ugur Sahin and Ryan Richardson.
How many employees does BioNTech have?
BioNTech has 1,941 employees.
What is BioNTech revenue?
Latest BioNTech annual revenue is €482.3 m.
What is BioNTech revenue per employee?
Latest BioNTech revenue per employee is €248.5 k.
Who are BioNTech competitors?
Competitors of BioNTech include APEIRON Biologics, Ohm Oncology and Kite Pharma.
Where is BioNTech headquarters?
BioNTech headquarters is located at An der Goldgrube 12, Mainz.
Where are BioNTech offices?
BioNTech has offices in Mainz, Halle (Saale), Idar-Oberstein, Marburg and in 4 other locations.
How many offices does BioNTech have?
BioNTech has 8 offices.
Receive alerts for 300+ data fields across thousands of companies